Kane Biotech Inc (KNE) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.880x

Based on the latest financial reports, Kane Biotech Inc (KNE) has a cash flow conversion efficiency ratio of 0.880x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-698.22K ≈ $-505.08K USD) by net assets (CA$-793.37K ≈ $-573.91K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Kane Biotech Inc - Cash Flow Conversion Efficiency Trend (2003–2024)

This chart illustrates how Kane Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read KNE liabilities breakdown for a breakdown of total debt and financial obligations.

Kane Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kane Biotech Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Beston Global Food Company Ltd AU:BFC	-1.028x
Kuke Music Holding Ltd NYSE:KUKE	-0.498x
PREMIER AFRICAN MINERALS F:0PA	N/A
Altur Slatina RO:ALT	N/A
ASTROTECH CORP. F:SP5	N/A
Gold Basin Resources Corp V:GXX	0.026x
ABM International Limited NSE:ABMINTLLTD	0.002x
ADDvise Group AB A ST:ADDV-A	0.032x

Annual Cash Flow Conversion Efficiency for Kane Biotech Inc (2003–2024)

The table below shows the annual cash flow conversion efficiency of Kane Biotech Inc from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see Kane Biotech Inc (KNE) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$-1.63 Million ≈ $-1.18 Million	CA$-4.11 Million ≈ $-2.97 Million	2.523x	+919.19%
2023-12-31	CA$-8.41 Million ≈ $-6.08 Million	CA$-2.08 Million ≈ $-1.51 Million	0.248x	-66.34%
2022-12-31	CA$-4.14 Million ≈ $-2.99 Million	CA$-3.04 Million ≈ $-2.20 Million	0.736x	-49.65%
2021-12-31	CA$-1.57 Million ≈ $-1.13 Million	CA$-2.29 Million ≈ $-1.66 Million	1.461x	+139.86%
2020-12-31	CA$1.07 Million ≈ $777.45K	CA$-3.94 Million ≈ $-2.85 Million	-3.665x	-221.02%
2019-12-31	CA$836.81K ≈ $605.33K	CA$-955.37K ≈ $-691.10K	-1.142x	-139.40%
2018-12-31	CA$-984.84K ≈ $-712.42K	CA$-2.85 Million ≈ $-2.06 Million	2.898x	+488.15%
2017-12-31	CA$2.74 Million ≈ $1.98 Million	CA$-2.04 Million ≈ $-1.48 Million	-0.747x	+57.43%
2016-12-31	CA$1.35 Million ≈ $974.76K	CA$-2.36 Million ≈ $-1.71 Million	-1.754x	+39.34%
2015-12-31	CA$480.25K ≈ $347.40K	CA$-1.39 Million ≈ $-1.00 Million	-2.891x	-265.11%
2014-12-31	CA$1.32 Million ≈ $958.43K	CA$-1.05 Million ≈ $-758.95K	-0.792x	+12.89%
2013-12-31	CA$1.28 Million ≈ $928.25K	CA$-1.17 Million ≈ $-843.79K	-0.909x	-84.75%
2012-12-31	CA$2.35 Million ≈ $1.70 Million	CA$-1.16 Million ≈ $-835.72K	-0.492x	-24.43%
2011-12-31	CA$2.38 Million ≈ $1.72 Million	CA$-940.30K ≈ $-680.20K	-0.395x	+41.91%
2010-12-31	CA$1.16 Million ≈ $841.74K	CA$-792.06K ≈ $-572.96K	-0.681x	-60.08%
2009-12-31	CA$1.80 Million ≈ $1.30 Million	CA$-764.26K ≈ $-552.85K	-0.425x	+40.87%
2008-12-31	CA$1.49 Million ≈ $1.08 Million	CA$-1.07 Million ≈ $-776.48K	-0.719x	-2.74%
2007-12-31	CA$1.14 Million ≈ $825.19K	CA$-798.38K ≈ $-577.53K	-0.700x	-18.27%
2006-12-31	CA$1.42 Million ≈ $1.03 Million	CA$-843.13K ≈ $-609.91K	-0.592x	+25.57%
2005-12-31	CA$1.02 Million ≈ $735.99K	CA$-808.87K ≈ $-585.12K	-0.795x	+32.63%
2004-12-31	CA$426.65K ≈ $308.63K	CA$-503.50K ≈ $-364.22K	-1.180x	-178.44%
2003-12-31	CA$955.27K ≈ $691.03K	CA$-404.87K ≈ $-292.88K	-0.424x	--

About Kane Biotech Inc

V:KNE Canada Biotechnology

Market Cap

$4.24 Million

CA$5.86 Million CAD

Market Cap Rank

#28663 Global

#1329 in Canada

Share Price

CA$0.04

Change (1 day)

+0.00%

52-Week Range

CA$0.03 - CA$0.08

All Time High

CA$0.40